Medly AI Raises £6M Seed Led by Felix Capital to Scale Its AI Exam Tutor

August 19, 2026

Medly AI, a London exam-preparation platform, has raised £6 million ($8 million) in a seed round led by Felix Capital, with existing backers Eka Ventures and Ada Ventures returning.

Roughly a third of 11 to 16-year-olds in the UK receive some form of private tutoring, and the evidence that one-to-one support lifts exam grades is not seriously disputed. The problem is price. Families who can afford a tutor buy their children individual attention, immediate feedback and structured practice; families who cannot are left with classroom provision and past papers. Medly's founders have framed the gap as one of the more fixable inequalities in British education, and the company has built its product around closing it.

The platform runs on a proprietary combination of seven large language models, layered with approaches drawn from neuroscience and teaching theory. Students answer practice questions and get marked in the moment, with an explanation of where marks were lost and what would have earned them — delivered as a conversation rather than a score on a worksheet. The system tracks progress against individual curriculum points and adjusts how it explains things to each student. Handwriting recognition lets students work on a tablet or with a stylus, which matters for Maths and Chemistry where typing is the wrong interface. Coverage spans GCSE, IGCSE, A-Level and the International Baccalaureate, with SAT prep recently launched in the US and APs and ACTs planned before the end of the year. Medly is also building its own models for UK and EEA marking and pedagogy rather than renting general-purpose ones indefinitely.

Since launching in February 2025, Medly has grown its user base by almost 600% and passed 400,000 users in the UK. Students preparing for an exam spend around an hour a day on the platform, and close to a million messages pass between students and their AI tutors daily. Of the students who used Medly to revise for last summer's GCSEs, 74% improved by at least one grade and 41% by two or more, with the largest gains in Physics and English Literature. In June, Medly was one of eight suppliers selected from 53 bids for the AI Tutoring Tools Pioneers Programme, run by the Department for Science, Innovation and Technology with the Department for Education, which funds research contracts aimed at raising attainment among disadvantaged pupils in England.

The round follows a £1.7 million pre-seed announced in February 2025 and led by Eka Ventures. Angels joining this time include InvestEngine chief executive Andrey Dobrynin, Creator Fund venture partner Al Giles, LearnLaunch general partner Jean Hammond and Episode 1 general partner Hector Mason. Angela Chou, the Felix Capital investor on the deal, pointed to the pace at which the company has scaled; Ada Ventures, which backed the pre-seed through its Inclusive Alpha fund, has stayed in. The capital will go towards growing the UK student base, international expansion — the US first — and widening the evidence base behind the platform, following a first paper on its marking performance against human examiners and a completed randomised controlled trial of more than 1,000 pupils in lower-attaining schools. Medly was founded by UCL medicine graduates Dr Paul Jung and Dr Kavi Samra, who met at secondary school at 11 and both left the NHS to build it.

Sources

Kavi Samra

Paul Jung

Medly AI